- AU$40.71m
- AU$31.48m
- AU$0.79m
- 65
- 19
- 20
- 28
Annual income statement for Inoviq, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.098 | 0.511 | 0.342 | 0.752 | 0.792 |
| Cost of Revenue | |||||
| Gross Profit | — | 0.447 | 0.286 | 0.707 | 0.711 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.36 | 14.5 | 20.6 | 9.72 | 7.35 |
| Operating Profit | -3.26 | -14 | -20.3 | -8.97 | -6.55 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.25 | -14 | -20.3 | -8.97 | -6.55 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.25 | -11.2 | -18.2 | -8.97 | -6.55 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.25 | -11.2 | -18.2 | -8.97 | -6.55 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.25 | -11.2 | -18.2 | -8.97 | -6.55 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.05 | -0.084 | -0.111 | -0.083 | -0.071 |